Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:18036392rdf:typepubmed:Citationlld:pubmed
pubmed-article:18036392lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:18036392lifeskim:mentionsumls-concept:C0237939lld:lifeskim
pubmed-article:18036392lifeskim:mentionsumls-concept:C0332307lld:lifeskim
pubmed-article:18036392lifeskim:mentionsumls-concept:C0011860lld:lifeskim
pubmed-article:18036392lifeskim:mentionsumls-concept:C0332281lld:lifeskim
pubmed-article:18036392lifeskim:mentionsumls-concept:C0071097lld:lifeskim
pubmed-article:18036392lifeskim:mentionsumls-concept:C0289313lld:lifeskim
pubmed-article:18036392lifeskim:mentionsumls-concept:C1707455lld:lifeskim
pubmed-article:18036392lifeskim:mentionsumls-concept:C1875307lld:lifeskim
pubmed-article:18036392pubmed:issue6 Pt 1lld:pubmed
pubmed-article:18036392pubmed:dateCreated2007-11-26lld:pubmed
pubmed-article:18036392pubmed:abstractTextOutcomes in patients with type 2 diabetes mellitus (DM) can differ based on the antidiabetic medication that is used. Thiazolidinediones (TZDs) are a newer class of agents used for the treatment of type 2 DM. No previous study has compared health care utilization associated with the 2 TZDs on the market.lld:pubmed
pubmed-article:18036392pubmed:languageenglld:pubmed
pubmed-article:18036392pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18036392pubmed:citationSubsetIMlld:pubmed
pubmed-article:18036392pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18036392pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18036392pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18036392pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18036392pubmed:statusMEDLINElld:pubmed
pubmed-article:18036392pubmed:monthJunlld:pubmed
pubmed-article:18036392pubmed:issn1879-114Xlld:pubmed
pubmed-article:18036392pubmed:authorpubmed-author:BalkrishnanRa...lld:pubmed
pubmed-article:18036392pubmed:authorpubmed-author:ArondekarBhak...lld:pubmed
pubmed-article:18036392pubmed:authorpubmed-author:AndersonRoger...lld:pubmed
pubmed-article:18036392pubmed:authorpubmed-author:CamachoFabian...lld:pubmed
pubmed-article:18036392pubmed:authorpubmed-author:ShenolikarRah...lld:pubmed
pubmed-article:18036392pubmed:authorpubmed-author:HorblyukRusla...lld:pubmed
pubmed-article:18036392pubmed:copyrightInfo(c) 2007 Excerpta Medica, Inc.lld:pubmed
pubmed-article:18036392pubmed:issnTypeElectroniclld:pubmed
pubmed-article:18036392pubmed:volume29lld:pubmed
pubmed-article:18036392pubmed:ownerNLMlld:pubmed
pubmed-article:18036392pubmed:authorsCompleteYlld:pubmed
pubmed-article:18036392pubmed:pagination1306-15lld:pubmed
pubmed-article:18036392pubmed:dateRevised2009-9-18lld:pubmed
pubmed-article:18036392pubmed:meshHeadingpubmed-meshheading:18036392...lld:pubmed
pubmed-article:18036392pubmed:meshHeadingpubmed-meshheading:18036392...lld:pubmed
pubmed-article:18036392pubmed:meshHeadingpubmed-meshheading:18036392...lld:pubmed
pubmed-article:18036392pubmed:meshHeadingpubmed-meshheading:18036392...lld:pubmed
pubmed-article:18036392pubmed:meshHeadingpubmed-meshheading:18036392...lld:pubmed
pubmed-article:18036392pubmed:meshHeadingpubmed-meshheading:18036392...lld:pubmed
pubmed-article:18036392pubmed:meshHeadingpubmed-meshheading:18036392...lld:pubmed
pubmed-article:18036392pubmed:meshHeadingpubmed-meshheading:18036392...lld:pubmed
pubmed-article:18036392pubmed:meshHeadingpubmed-meshheading:18036392...lld:pubmed
pubmed-article:18036392pubmed:meshHeadingpubmed-meshheading:18036392...lld:pubmed
pubmed-article:18036392pubmed:meshHeadingpubmed-meshheading:18036392...lld:pubmed
pubmed-article:18036392pubmed:meshHeadingpubmed-meshheading:18036392...lld:pubmed
pubmed-article:18036392pubmed:meshHeadingpubmed-meshheading:18036392...lld:pubmed
pubmed-article:18036392pubmed:meshHeadingpubmed-meshheading:18036392...lld:pubmed
pubmed-article:18036392pubmed:meshHeadingpubmed-meshheading:18036392...lld:pubmed
pubmed-article:18036392pubmed:meshHeadingpubmed-meshheading:18036392...lld:pubmed
pubmed-article:18036392pubmed:meshHeadingpubmed-meshheading:18036392...lld:pubmed
pubmed-article:18036392pubmed:meshHeadingpubmed-meshheading:18036392...lld:pubmed
pubmed-article:18036392pubmed:year2007lld:pubmed
pubmed-article:18036392pubmed:articleTitleComparisons of rosiglitazone versus pioglitazone monotherapy introduction and associated health care utilization in Medicaid-enrolled patients with type 2 diabetes mellitus.lld:pubmed
pubmed-article:18036392pubmed:affiliationDepartment of Pharmacy Practice and Administration, The Ohio State University, Columbus, Ohio 43210, USA. balkrishnan.l@osu.edulld:pubmed
pubmed-article:18036392pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:18036392pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:18036392pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed